Clinical Trial Update: A Study of the Efficacy and Safety of Enclitide Chloride (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-008) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of Enclitide Chloride (MK-0616) as an oral PCSK9 inhibitor in adults with hypercholesterolemia, including famil…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Hypercholesterolemia
• Hypercholesterolemia

Drugs mentioned

• Enclitide Chloride (MK-0616) (enclitide chloride)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hypercholesterolemia, Familial Hypercholesterolemia | Phase 2 | Status: COMPLETED | Results posted: 2023-12-06